“Bimekizumab 4-Year Efficacy in High-Impact Areas in Moderate to Severe Plaque Psoriasis: Pooled Results from BE BRIGHT”. 2024. SKIN The Journal of Cutaneous Medicine 8 (6): s432. https://doi.org/10.25251/skin.8.supp.432.